Investigating antibiotic resistance in bacteria
Heteroresistance Interdisciplinary Research Unit
This study is looking at why some bacteria can survive antibiotics while others can't, with the goal of finding better ways to treat infections, so patients can have more effective treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11037941 on NIH RePORTER |
What this research studies
This research focuses on understanding a specific type of antibiotic resistance known as heteroresistance, where some bacteria can survive antibiotic treatment while others cannot. The team aims to uncover the mechanisms behind this phenomenon and its implications for treating infections. By studying how resistant and susceptible bacterial populations behave during antibiotic exposure, the research seeks to develop new strategies to combat these challenging infections. Patients may benefit from improved treatment options as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from infections caused by antibiotic-resistant bacteria, particularly those involving Acinetobacter baumannii.
Not a fit: Patients with infections that are not caused by antibiotic-resistant bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for antibiotic-resistant infections, potentially saving lives.
How similar studies have performed: Other research has shown success in understanding antibiotic resistance mechanisms, but the specific focus on heteroresistance is relatively novel.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Weiss, David S — Emory University
- Study coordinator: Weiss, David S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.